DCL: Explanation for consolidated business result in Q3/2013

Cuu Long Pharmaceutical Joint Stock Corporation explained the fluctuation in profit in Quarter 3/2013 compared to Quarter 3/2012:

-         Profit after tax in consolidated financial statement Q3/2013: VND8,656,000,573

-         Profit after tax in consolidated financial statement Q3/2012: VND7,430,966,651

-         Profit after tax in Q3/2013 increased VND1,225,033,922 (equivalent to 10%) compared to the same period of 2012 because the financial expenses, especial interest expense, in Q3/2013 were VND8.6 billion, decreasing VND1.4 billion compared to Q3/2012.

HOSE

>   ELC: Explanation for business result in Q3/2013 (11/11/2013)

>   SAM: Explanation for consolidated business result in Q3/2013 (11/11/2013)

>   PXT: Explanation for business result in Q3, 2013 - Revised (11/11/2013)

>   S12: Financial Statement Quarter 3/2013 (11/11/2013)

>   SDA: Financial Statement Quarter 3/2013 (11/11/2013)

>   LHC: Financial Statement Quarter 3/2013 (holding company) (11/11/2013)

>   SHB, VRG renew cooperation deal (11/11/2013)

>   MNC: Financial Statement Quarter 3/2013 (11/11/2013)

>   LHC: Financial Statement Quarter 3/2013 (11/11/2013)

>   SPI: Notice of record date for extraordinary General Meeting of Shareholders 2013 (11/11/2013)